Single-Arm Phase Ii Trial Of Dual Inhibition Of Egfr With Afatinib And Cetuximab With Correlative Studies In The Treatment Of Advanced Squamous Cell Cancers Of The Head And Neck

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK(2021)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要